Astrana Health (NASDAQ:ASTH) Sees Unusually-High Trading Volume – Still a Buy?

Astrana Health, Inc. (NASDAQ:ASTH) shares saw unusually-strong trading volume on Friday . Approximately 288,697 shares changed hands during mid-day trading, a decline of 16% from the previous session’s volume of 341,991 shares.The stock last traded at $28.21 and had previously closed at $33.36.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on ASTH shares. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astrana Health in a research report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, Astrana Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $47.40.

Astrana Health Price Performance

The company has a market capitalization of $1.55 billion, a price-to-earnings ratio of 54.32, a PEG ratio of 0.90 and a beta of 0.80. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.52. The company’s 50 day simple moving average is $30.57 and its 200-day simple moving average is $27.96.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Wednesday, January 10th. The company reported $0.50 earnings per share (EPS) for the quarter. The business had revenue of $317.00 million for the quarter. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. On average, equities research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

Large investors have recently added to or reduced their stakes in the business. Bastion Asset Management Inc. purchased a new stake in Astrana Health in the 3rd quarter valued at about $604,000. Public Sector Pension Investment Board grew its stake in shares of Astrana Health by 18.3% during the 3rd quarter. Public Sector Pension Investment Board now owns 167,490 shares of the company’s stock valued at $4,748,000 after buying an additional 25,949 shares during the period. Linden Thomas Advisory Services LLC grew its stake in shares of Astrana Health by 4.4% during the 3rd quarter. Linden Thomas Advisory Services LLC now owns 28,665 shares of the company’s stock valued at $813,000 after buying an additional 1,199 shares during the period. Diamond Hill Capital Management Inc. raised its position in shares of Astrana Health by 33.0% in the 3rd quarter. Diamond Hill Capital Management Inc. now owns 361,264 shares of the company’s stock worth $10,242,000 after buying an additional 89,733 shares during the period. Finally, Savant Capital LLC grew its position in Astrana Health by 2.2% during the third quarter. Savant Capital LLC now owns 30,713 shares of the company’s stock valued at $871,000 after acquiring an additional 649 shares during the period. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.